Close

Brainstorm Cell Therapeutics (BCLI) Misses Q4 EPS by 3c

March 26, 2015 8:31 AM EDT

Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q4 EPS of ($0.18), $0.03 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Brainstorm Cell Therapeutics (BCLI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings